MEDLINEplus Health Information: Return to home page   A service of the National Library of Medicine: Go to NLM home page
Search     Advanced Search    Site Map    About MEDLINEplus    Home
Health Topics: conditions, diseases and wellness Drug Information: generic and brand name drugs Dictionaries: spellings and definitions of medical terms Directories: doctors, dentists and hospitals Other Resources: organizations, libraries, publications, MEDLINE

Medical Encyclopedia

Disease     Injury     Nutrition     Poison     Special     Surgery     Symptoms     Tests

Kidney anatomy
 
Overview   Symptoms   Treatment   Prevention   

Membranoproliferative GN I

Alternative names:

glomerulonephritis - membranoproliferative (type 1); lobular GN; membranoproliferative glomerulonephritis type 1; mesangiocapillary glomerulonephritis (type 1); MPGN1

Definition:

A kidney disorder that results in disrupted kidney function, caused by inflammation and changes in the structure of kidney cells.

Causes, incidence, and risk factors:

The glomeruli are the inner structures of the kidney. They include small capillaries surrounded by membranes through which the blood is filtered to form urine. Glomerulonephritis involves inflammation of the glomeruli. Membranoproliferative glomerulonephritis (MPGN) is a form of glomerulonephritis caused by an abnormal immune response, with deposits of antibodies in the kidneys. Certain cells in the capillary wall (mesangial cells) increase in number and the parts of the glomerular membranes change in structure. Type 1 MPGN involves deposits of antibodies in the subendothelial layer of the glomerular membrane.

Almost all cases of membranoproliferative glomerulonephritis are type 1. (A few are type 2 MPGN). MPGN 1 occurs in about 3 out of 10,000 people. Both sexes are affected. The disorder affects mostly people under age 50.

Membranoproliferative GN 1 may present in several forms. The glomerular membrane disruption causes a change in urine filtration, making the glomerulus permeable to protein and blood cells. This is manifested as acute nephritic syndrome, nephrotic syndrome, or abnormal urinalysis without symptoms. MPGN accounts for about 5 to 10% of all cases of nephrotic syndrome (excessive excretion of protein in the urine accompanied by swelling of the body).

White blood cells may be excreted in the urine, causing it to have a cloudy appearance. Urine output decreases because of reduced glomerular filtration rate. Swelling may occur as sodium and water are retained in the body.

Protein in the bloodstream keeps fluid within the blood vessels. Edema is increased when protein is lost because fluid leaks out of blood vessels into the tissues. Hypertension occurs due to the cumulative effects of water and sodium retention, and increased production of renin (a hormone that regulates blood pressure) by the damaged kidney.

Nitrogenous waste products such as urea (see BUN) and creatinine may accumulate in the blood (azotemia) because of poor kidney functioning. The disorder is often progressive and eventually results in chronic renal failure.


Adam

The information provided herein should not be used for diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Copyright 2000 adam.com, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

Health Topics | Drug Information | Dictionaries | Directories | Other Resources